Cigna Group $CI Stock: IFP Advisors Inc Raises Position

Key Points

• IFP Advisors increased its Cigna stake by 32% in the third quarter, owning 17,337 shares valued at approximately $4.7 million. Institutional investors collectively own 86.99% of Cigna’s outstanding stock.
• Cigna reported quarterly EPS of $7.78, exceeding estimates of $7.60, while revenue rose 6.7% year over year to $71.56 billion. The company maintained fiscal 2026 EPS guidance of approximately $30.45.
• Cigna’s shares opened at $299.10, and analysts maintain a “Moderate Buy” consensus rating with an average price target of $338.24. The company also declared a quarterly dividend of $1.56, equivalent to a 2.1% annualized yield.

IFP Advisors Inc increased its stake in shares of Cigna Group (NYSE:CI - Free Report) by 32.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 17,337 shares of the health services provider's stock after purchasing an additional 4,205 shares during the quarter. IFP Advisors Inc's holdings in Cigna Group were worth $4,713,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of CI. Alpine Bank Wealth Management raised its stake in shares of Cigna Group by 7.7% during the third quarter. Alpine Bank Wealth Management now owns 1,463 shares of the health services provider's stock valued at $398,000 after acquiring an additional 105 shares in the last quarter. Kintegral Advisory LLC raised its holdings in shares of Cigna Group by 0.6% in the 3rd quarter. Kintegral Advisory LLC now owns 15,123 shares of the health services provider's stock valued at $4,111,000 after purchasing an additional 85 shares in the last quarter. TD Waterhouse Canada Inc. boosted its stake in shares of Cigna Group by 15.6% during the third quarter. TD Waterhouse Canada Inc. now owns 43,077 shares of the health services provider's stock valued at $11,710,000 after purchasing an additional 5,803 shares in the last quarter. Howard Capital Management LLC raised its stake in Cigna Group by 1,187.7% in the third quarter. Howard Capital Management LLC now owns 24,904 shares of the health services provider's stock worth $6,770,000 after buying an additional 22,970 shares in the last quarter. Finally, V Square Quantitative Management LLC lifted its holdings in Cigna Group by 4.4% during the third quarter. V Square Quantitative Management LLC now owns 6,052 shares of the health services provider's stock worth $1,645,000 after buying an additional 256 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,677 shares of Cigna Group stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the transaction, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. This trade represents a 9.37% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the company's stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the transaction, the insider owned 5,053 shares of the company's stock, valued at approximately $1,435,304.65. The trade was a 10.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,730 shares of company stock worth $6,293,359 over the last quarter. 0.60% of the stock is owned by company insiders.

Cigna Group Price Performance

Shares of CI stock opened at $299.10 on Tuesday. The firm's 50-day moving average is $279.29 and its two-hundred day moving average is $282.22. The company has a market capitalization of $79.03 billion, a PE ratio of 9.60, a price-to-earnings-growth ratio of 1.02 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 12 month low of $239.51 and a 12 month high of $311.34.

Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts' consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. The company had revenue of $71.56 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter in the previous year, the business earned $7.20 earnings per share. The company's revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts predict that Cigna Group will post 30.50 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th were paid a $1.56 dividend. The ex-dividend date was Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. Cigna Group's dividend payout ratio (DPR) is currently 25.82%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on CI shares. Jefferies Financial Group downgraded Cigna Group from a "buy" rating to a "hold" rating and reduced their price target for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. UBS Group restated a "buy" rating on shares of Cigna Group in a research note on Thursday, October 1st. Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a research note on Friday, July 31st. Raymond James Financial cut shares of Cigna Group from a "strong-buy" rating to an "outperform" rating and reduced their target price for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Finally, Piper Sandler set a $370.00 target price on Cigna Group and gave the stock an "overweight" rating in a report on Friday, October 2nd. Fifteen research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $338.24.

Cigna Group Profile

The Cigna Group NYSE: CI is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.